These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 2959449)
1. Plasma concentrations of 3-keto-desogestrel after oral administration of desogestrel and intravenous administration of 3-keto-desogestrel. Back DJ; Grimmer SF; Shenoy N; Orme ML Contraception; 1987 Jun; 35(6):619-26. PubMed ID: 2959449 [TBL] [Abstract][Full Text] [Related]
2. The effect of oestrogen dose and progestogen type on haemostatic changes in women taking low dose oral contraceptives. Norris LA; Bonnar J Br J Obstet Gynaecol; 1996 Mar; 103(3):261-7. PubMed ID: 8630312 [TBL] [Abstract][Full Text] [Related]
3. Serum steroid binding protein concentrations, distribution of progestogens, and bioavailability of testosterone during treatment with contraceptives containing desogestrel or levonorgestrel. Hammond GL; Langley MS; Robinson PA; Nummi S; Lund L Fertil Steril; 1984 Jul; 42(1):44-51. PubMed ID: 6233179 [TBL] [Abstract][Full Text] [Related]
4. Desogestrel- and levonorgestrel-containing oral contraceptives have different effects on urinary excretion of prostacyclin metabolites and serum high density lipoproteins. Ylikorkala O; Kuusi T; Tikkanen MJ; Viinikka L J Clin Endocrinol Metab; 1987 Dec; 65(6):1238-42. PubMed ID: 2960690 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of 3-keto-desogestrel and ethinylestradiol released from different types of contraceptive vaginal rings. Timmer CJ; Apter D; Voortman G Contraception; 1990 Dec; 42(6):629-42. PubMed ID: 2150632 [TBL] [Abstract][Full Text] [Related]
6. Serum pharmacokinetics of orally administered desogestrel and binding of contraceptive progestogens to sex hormone-binding globulin. Bergink W; Assendorp R; Kloosterboer L; van Lier W; Voortman G; Qvist I Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 2):2132-7. PubMed ID: 2147817 [TBL] [Abstract][Full Text] [Related]
7. A cross-over study of three oral contraceptives containing ethinyloestradiol and either desogestrel or levonorgestrel. Song S; Chen JK; Yang PJ; He ML; Li LM; Fan BC; Rekers H; Fotherby K Contraception; 1992 Jun; 45(6):523-32. PubMed ID: 1535580 [TBL] [Abstract][Full Text] [Related]
8. Oral contraceptives containing 20 or 30 micrograms ethinylestradiol and 150 micrograms desogestrel: pharmacokinetics and pharmacodynamic parameters. Jung-Hoffmann C; Fitzner M; Kuhl H Horm Res; 1991; 36(5-6):238-46. PubMed ID: 1823082 [TBL] [Abstract][Full Text] [Related]
9. A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins. Crook D; Godsland IF; Worthington M; Felton CV; Proudler AJ; Stevenson JC Am J Obstet Gynecol; 1993 Nov; 169(5):1183-9. PubMed ID: 8238183 [TBL] [Abstract][Full Text] [Related]
10. Serum levels of 3-keto-desogestrel after oral administration of desogestrel and 3-keto-desogestrel. Hasenack HG; Bosch AM; Käär K Contraception; 1986 Jun; 33(6):591-6. PubMed ID: 2945700 [TBL] [Abstract][Full Text] [Related]
11. Insulin resistance, secretion, and metabolism in users of oral contraceptives. Godsland IF; Walton C; Felton C; Proudler A; Patel A; Wynn V J Clin Endocrinol Metab; 1992 Jan; 74(1):64-70. PubMed ID: 1530790 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of a triphasic oral contraceptive containing desogestrel and ethinyl estradiol. Archer DF; Timmer CJ; Lammers P Fertil Steril; 1994 Apr; 61(4):645-51. PubMed ID: 8150105 [TBL] [Abstract][Full Text] [Related]
13. Clinical and metabolic study of a new pill containing 20 mcg ethinylestradiol plus 0.150 mg desogestrel. Fioretti P; Fruzzetti F; Navalesi R; Ricci C; Miccoli R; Cerri M; Orlandi MC; Melis GB Contraception; 1987 Mar; 35(3):229-43. PubMed ID: 2956055 [TBL] [Abstract][Full Text] [Related]
14. Multicenter trial of a monophasic oral contraceptive containing ethinyl estradiol and desogestrel. Rekers H Acta Obstet Gynecol Scand; 1988; 67(2):171-4. PubMed ID: 2972160 [TBL] [Abstract][Full Text] [Related]
15. Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol. Akerlund M; Røde A; Westergaard J Br J Obstet Gynaecol; 1993 Sep; 100(9):832-8. PubMed ID: 8218004 [TBL] [Abstract][Full Text] [Related]
16. The pharmacokinetics of ethynylestradiol in the presence and absence of gestodene and desogestrel. Orme M; Back DJ; Ward S; Green S Contraception; 1991 Apr; 43(4):305-16. PubMed ID: 1830266 [TBL] [Abstract][Full Text] [Related]
17. Comparative study on the efficacy and acceptability of two contraceptive pills administered by the vaginal route: an international multicenter clinical trial. Coutinho EM; de Souza JC; da Silva AR; de Acosta OM; Alvarez F; Brache V; Garza Flores J; Vasquez-Estrada L; Santo R; Bassol S Clin Pharmacol Ther; 1993 Jan; 53(1):65-75. PubMed ID: 8422744 [TBL] [Abstract][Full Text] [Related]
18. Oral contraceptive tablets containing 20 and 30 micrograms of ethinyl estradiol with 150 micrograms desogestrel. Their influence on lipids, lipoproteins, sex hormone binding globulin and testosterone. Akerlund M; Almström E; Högstedt S; Nabrink M Acta Obstet Gynecol Scand; 1994 Feb; 73(2):136-43. PubMed ID: 8116352 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of contraceptive steroids in patients with cystic fibrosis. Stead RJ; Grimmer SF; Rogers SM; Back DJ; Orme ML; Hodson ME; Batten JC Thorax; 1987 Jan; 42(1):59-64. PubMed ID: 3112991 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of desogestrel. McClamrock HD; Adashi EY Am J Obstet Gynecol; 1993 Mar; 168(3 Pt 2):1021-8. PubMed ID: 8447355 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]